Opioid and Alcohol Use Disorders in Older Adults: Working Group Guideline Development (1.5 CME)
(1.5 CME) In this conference recording from the 2018 Annual Conference, you will learn how alcohol has now surpassed tobacco as the leading cause of hospital admission in some Canadian provinces, yet alcohol use disorders among those 65 and older often go unidentified and untreated. In addition, older adults are over-represented among Canadians who have had fatal or non-fatal opioid overdoses , yet identification and treatment of opioid use disorders as well as appropriate use of opioids for chronic non-cancer pain remain a challenge for many clinicians.
The Canadian Coalition for Seniors Mental Health (CCSMH) has been tasked by Health Canada to develop guidelines for the assessment and treatment of four substance use disorders in older adults (alcohol, opioids, cannabis, and benzodiazepines). As part of guideline development, input is needed from peers working and researching in the field. In this interactive workshop Drs. Rieb and Butt will present a brief overview of the methods used to review literature on the assessment and treatment of alcohol and opioid use disorders in older adults, then share draft guidelines developed by the working groups of the CCSMH. Workshop participants will be encouraged to give feedback and share clinical and research findings to augment the guidelines. Physicians, nurse practitioners, counselors, psychologists, researchers, administrators, and older adults in recovery are among those encouraged to attend for a lively discussion.
Launette Marie Rieb
MD, MSc, CCFP, FCFP, DABAM, FASAM
Dr. Launette Rieb is a Clinical Associate Professor in the Department of Family Practice at the University of British Columbia (UBC), Canada. She is a Family Physician and diplomat of The American Board of Addiction Medicine. She did her graduate work in the area of pain physiology. She completed a postgraduate UBC Clinical Scholar's Program in 2015 and a NIDA sponsored Canadian Addiction Medicine Research Fellowship in 2016 resulting in publication on a newly described opioid pain phenomenon - withdrawal-associated injury-site pain (WISP). She has also published on fentanyl and heroin overdose deaths in BC, as well as on addiction in a variety of marginalized populations. Dr. Rieb is the Medical Director of a multidisciplinary team at OrionHealth (Vancouver Pain Clinic), and works as a consultant for the Rapid Access Addictions Clinic at St. Paul’s Hospital in Vancouver. In addition, she does addiction medicine consultations for The Orchard Recovery Centre, on Bowen Island. Dr. Rieb has taught addiction medicine in the undergraduate and postgraduate medical programs at UBC, and at national and international conferences for 24 years. Dr. Rieb was the co-creator and initial Physician Director of the St. Paul’s Hospital Goldcorp Addiction Medicine Fellowship (now the BC Centre on Substance Use Addiction Medicine Fellowship). She is a member of the Canadian Society of Addiction Medicine’s Education Committee and the College of Family Physician of Canada's Competency Creation Working Group for the Certificate of Added Competency in Addiction Medicine. Dr. Rieb is the past recipient of a UBC Faculty of Medicine Post Graduate Teaching Award.
Peter R. Butt
MD, CCFP, FCFP
Dr. Peter Butt is a graduate of McMaster University and a Certificant and Fellow with the College of Family Physicians of Canada. He is an Associate Professor in the Department of Family Medicine at the University of Saskatchewan in a position dedicated to Addiction Medicine, and serves as a consultant to Mental Health and Addictions in the Saskatoon Health Region. National committee work includes the National Alcohol Strategy Advisory Committee, chair of the Canadian Alcohol Low Risk Drinking Guidelines Expert Advisory Group, co-chair of the Standard Drink Label Working Group, and member of the National Recovery Advisory Committee for the Canadian Centre on Substance Abuse; and physician lead on the Alcohol Screening, Brief Intervention and Referral project for the College of Family Physicians of Canada. Provincially he is the physician lead on the Saskatchewan provincial “Take Home Naloxone”project, chairs the Opioid Advisory Committee for the College of Physicians and Surgeons of Saskatchewan, and serves on the Health Canada - First Nation Prescription Drug Abuse Initiative.
ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American Society of Addiction Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABPM Maintenance of Certification (MOC)
The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1.5 LLSA credits towards ABPM MOC Part II requirements.
ABAM Transitional Maintenance of Certification (tMOC)
This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 1.5 AMA PRA Category 1 Credit(s)™ for completing this course.